Candel Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Needham, MA
CADL chart
What traders are saying about $CADL
Latest postsCandel Therapeutics, Inc. news
- Weekly Recap: Linoserpaturev survival data and stock option grants
TradingView ·
- Candel Therapeutics, Inc. (CADL) stock price, news, quote and history
Yahoo Finance UK ·
- Candel Therapeutics, Inc. (CADL) Seasonal Returns Chart
Yahoo! Finance Canada ·
- Candel Therapeutics Stock Price Forecast. Should You Buy CADL?
StockInvest.us ·
- New findings on aglatimagene and linoserpaturev released by Candel Therapeutics
Traders Union ·
- Candel Therapeutics reveals promising immune ac...
Pluang ·
- Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio
Yahoo Finance ·
- 315,000 options granted by Candel Therapeutics (CADL) carry an $8.82 exercise price.
Stock Titan ·
- Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer
Yahoo Finance ·
- Candel Therapeutics to Present at November Investor Conferences
Yahoo Finance ·
Candel Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $125,000 |
| Net income | -$38.2M | -$55.2M | -$37.9M | -$18.8M |
| Diluted EPS | $-0.72 | $-1.74 | $-1.31 | $-0.65 |
| Total assets (year end) | $125.2M | $106.9M | $41.2M | $77.7M |
| Cash and equivalents (year end) | $119.7M | $102.7M | $35.4M | $70.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Candel Therapeutics, Inc.
- Ticker
- CADL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Needham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1841387
Frequently asked questions
What exchange is Candel Therapeutics, Inc. listed on?
Candel Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CADL.
What industry is Candel Therapeutics, Inc. in?
Candel Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Candel Therapeutics, Inc. headquartered?
Candel Therapeutics, Inc.'s business address on file with the SEC is in Needham, MA.
When does Candel Therapeutics, Inc.'s fiscal year end?
Candel Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Candel Therapeutics, Inc. report?
Candel Therapeutics, Inc. reported $125,000 in revenue for calendar year 2022, according to its SEC filings.